Insomnia Treatment with Doxepin and Zolpidem

Efficacy Comparison

Zolpidem demonstrates clinically significant improvement in sleep onset latency, reducing time to fall asleep by approximately 11-19 minutes compared to placebo, as recommended by the American Academy of Sleep Medicine 1, 2
The American Academy of Sleep Medicine provides a weak recommendation for zolpidem use in treating both sleep onset and maintenance insomnia 1
The American College of Physicians recommends cognitive behavioral therapy for insomnia as first-line treatment before considering pharmacologic options like doxepin or zolpidem 5

Zolpidem is associated with small but potentially significant increases in amnesia, dizziness, and somnolence compared to placebo, according to the American Academy of Sleep Medicine 1
Zolpidem carries risks of complex behaviors including sleep driving, hallucinations, and other neuropsychiatric symptoms, as reported in the Annals of Internal Medicine 3

For sleep onset insomnia, zolpidem is preferred due to faster sleep onset, with a recommended starting dose of 5mg for adults, especially women and elderly, as suggested by the American Academy of Sleep Medicine 1, 2
Abrupt discontinuation of zolpidem can lead to rebound insomnia and withdrawal symptoms, including seizures in some cases, highlighting the need for a slow tapering protocol when discontinuing 6
Both medications should be used as adjuncts to cognitive behavioral therapy for insomnia rather than as standalone treatments, as recommended by the American College of Physicians 5